Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Novel cancer-selective and disease subtype-independent mechanistic targets of withaferin A in human breast cancer cells

ABSTRACT: We report differential gene expression changes by withaferin A in breast cancer cells versus a normal mammary epithelial cell line.

ORGANISM(S): Homo sapiens

PROVIDER: GSE158085 | GEO | 2020/09/17

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

RNA-seq reveals novel cancer-selective and disease subtype-independent mechanistic targets of withaferin A in human breast cancer cells.

Project description: Not available

| S-EPMC7736309 | biostudies-literature

Novel cancer-selective and disease subtype-independent mechanistic targets of withaferin A in human breast cancer cells

Project description:Novel cancer-selective and disease subtype-independent mechanistic targets of withaferin A in human breast cancer cells

| PRJNA663908 | ENA

RNA-Seq reveals novel mechanistic targets of withaferin A (WA) in prostate cancer cells

Project description:RNA-Seq reveals novel mechanistic targets of withaferin A (WA) in prostate cancer cells

| PRJNA565770 | ENA

RNA-seq reveals novel mechanistic targets of withaferin A in prostate cancer cells.

Project description: Not available

| S-EPMC7351133 | biostudies-literature

RNA-Seq reveals novel mechanistic targets of withaferin A (WA) in prostate cancer cells

Project description:RNA-Seq analysis using WA-treated 22Rv1 human prostate cancer cells revealed upregulation and downregulation of 6993 and 6607 genes, respectively when compared to the vehicle-treated control. The pathways with significantly upregulated gene expression following WA treatment included mitogen-activated protein kinases, focal adhesion, endocytosis, and autophagy as revealed by KEGG and gene ontology analyses. WA treatment also resulted in downregulation of genes associated with metabolic pathways, oxidative phosphorylation, tricarboxylic acid cycle, cell cycle, and base excision repair. This study identifies novel mechanistic targets of WA in prostate cancer.

2019-09-17 | GSE137519 | GEO

A natural plant derived compound, Withaferin A exploits the stress pathway to induce antitumor immunity

Project description:Analysis of the global effect of plant derived compound Withaferin A on gene expression in rat her-2/neu expressing murine cancer cells at an early time point of 6hrs post treatment. Pathway analyses were performed to determine which metabolic pathways were significantly affected by the Withaferin A.

2014-12-31 | GSE43374 | GEO

Disease Subtype-Independent Biomarkers of Breast Cancer Chemoprevention by the Ayurvedic Medicine Phytochemical Withaferin A.

Project description: Not available

| S-EPMC5928779 | biostudies-literature

Withaferin A (WA) causes cell death in prostate cells.

Project description:Withaferin A (WA), a major chemical component of an Indian herb Withania somnifera, induces cell death (apoptosis/necrosis) in a variety of tumor cells, but its molecular mechanism remains elusive. We report that WA induces cell death selectively in high-grade prostate (PC-3 and DU-145) and tongue (SAS) cancer cells but not in normal human fibroblast (TIG-1) and low-grade prostate cancer (LNCaP) cells. To identify genes whose expression levels were up- or down-regulated in prostate cancer cells following WA treatment, we examined the transcriptome profiles of mRNA prepared from TIG-1, LNCaP, PC-3 and DU-145 cells using Agilent’s Whole Human Genome Microarray.

2015-08-02 | E-GEOD-55728 | biostudies-arrayexpress

Small RNA next genration sequencing of miRNAs in Withaferin A treated MDA-MB-231 cells.

Project description:In this study, we reporte the altered miRNAs expression in the human triple negative breast cancer cell line (MDA-MB-231) in response to withaferin A at IC50 (2 µM) concentration.

2023-01-25 | GSE183395 | GEO

Withaferin A (WA) causes cell death in prostate cells.

2015-08-02 | GSE55728 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data